Drug Discovery Scientist, Former Sir Henry Wellcome Fellow, Melton Foundation Alumnus
London, UK
Joined July 2014
- Tweets115
- Following145
- Followers86
- Likes162
Sabine Reichert retweeted
After nearly 7 years, my PhD work is out in @Nature! Big big thank you to everyone involve within the @realRihellab and the 🐟 floor @uclcdb
nature.com/articles/s41586-0…
Our preprint 'Sleep pressure modulates single-neuron synapse dynamics in zebrafish' just dropped on @biorxivpreprint - A concerted effort from @realRihellab @ZWithTheFishes @_LizBroom 🐟💤 🧵👇🏻
Sabine Reichert retweeted
"It is a colossal failure that we are wasting such a valuable talent resource"
Our CSO, Anne, wrote in @Labiotech_eu's #IWD23 feature about why we must advance women into leadership positions where they can make the greatest contributions.
Read it here: labiotech.eu/trends-news/wom…
Such an amazing achievement of our team @benevolent_ai! So proud to be part of this innovative, collaborative company #baricitinib #recoverytrial
We first identified #baricitinib as a potential treatment for #COVID19 in Jan 2020. 9 clinical trials involving 12,000 patients globally, found that the use of #baricitinib reduces deaths in hospitalised #COVID19 patients by approximately one-fifth. benevolent.com/news/recovery…
Sabine Reichert retweeted
We have expanded our #AIDrugDiscovery collaboration with @AstraZeneca, adding systemic lupus erythematosus & heart failure to existing work in chronic kidney disease & idiopathic pulmonary fibrosis.
Learn more: benevolent.com/news/benevole…
#BenevolentNews
Sabine Reichert retweeted
At BenevolentAI, our interns aren’t just ‘interns’, they’re a part of our team and we value the expertise and insight they bring to the table.
Check out our blog to learn what to expect from an internship at Benevolent: benevolent.com/news/meet-our…
#InternAtBenevolent #Internships
Sabine Reichert retweeted
Our @AstraZeneca collaboration uniquely combines AI with scientific expertise.
Having already delivered two novel targets to AstraZeneca’s portfolio, we are looking to continue the momentum in two additional disease areas: heart failure & lupus.
fiercebiotech.com/medtech/as…
Really excited to have been part of this collaboration and worked with such an amazing team at AstraZeneca
Today we announced a second important milestone in our collaboration with @AstraZeneca, who have progressed a novel target for #idiopathicpulmonaryfibrosis into their portfolio.
Learn more: benevolent.com/news/benevole…
#BecauseItMatters #IPF #AIDrugDiscovery #MachineLearning
Sabine Reichert retweeted
My department is hiring at Associate Prof level. Please RT! tinyurl.com/aebb2zmt
Sabine Reichert retweeted
#WorkAtBenevolent: We are hiring a talented #Software #Engineer to join our team in #NewYork and contribute to designing, building and developing our AI-driven drug discovery platform.
Apply here ➡️ benevolent.com/jobs/senior-s…
Sabine Reichert retweeted
RT: seeking a postdoc trained in PROTEIN BIOLOGY eager to discover protein-protein and protein-RNA interactions in axons, to join our @wellcometrust funded “RNA dynamics in axons” sub-team
@timeshighered @NatureCareers
@dev_neuro @MRC_CNDD
Apply link: jobs.kcl.ac.uk/gb/en/job/029…
Sabine Reichert retweeted
Our collaboration with @AstraZeneca fuses AI & disease expertise to transform drug discovery.
This video series explores how our joint team used our technology to identify a novel target for CKD.
Watch more: youtube.com/watch?v=UpqT1ux9… #AIDrugDiscovery #Innovation #biotech
Sabine Reichert retweeted
We are looking for biological scientists to provide leadership for small molecule drug discovery programs from hit-ID through to preclinical development. Come join our multi-disciplinary team of dynamic and passionate scientists: #WorkAtBenevolent benevolent.com/jobs/drug-dis…
Sabine Reichert retweeted
Join us on 20 May for the inaugural Lewis Wolpert Memorial Lecture, honouring the life of Prof Wolpert - leading Developmental Biologist, author, humanist and broadcaster. Register at: eventbrite.co.uk/e/ucl-cdb-s… #lewiswolpert #evolutionarybiology #uclcdb @uclbiosciences @ucl
Sabine Reichert retweeted
We're pleased to share an important milestone in our in-house drug pipeline: the first patient has been dosed in the randomised first-in-human clinical trial of BEN-2293, a molecule designed & developed by Benevolent scientists to treat #AtopicDermatitis. ow.ly/9XzP50Dxr1c
Please share in your networks. @benevolent_ai are holding a virtual networking event to demystify machine learning in drug discovery
We will be holding our first virtual #WomenInTech meetup, which will look to demystify AI in drug discovery in order to empower female tech talent to take the leap into this important growth industry. We'd love to see you there. #meetup #BenevolentCareers
benevolent.com/news/careers-…
We are hiring a Drug Discovery Project Lead. If you are interested or know anyone who is, feel free to get in touch. benevolent.com/jobs/drug-dis…
Sabine Reichert retweeted
We're #hiring a safety pharmacology expert to provide significant support to our growing portfolio of small molecule drug discovery programs & disease deployments. If you'd like to join our eclectic team, please get in touch. #sciencejobs #CambridgeJobs benevolent.com/jobs/principa…
So exciting to see that our technology platforms make such important contributions @benevolent_ai
Pleased to confirm data from the @NIH @NIAIDNews ACTT-2 trial showing that baricitinib combined with remdesivir significantly reduced patient recovery time, further validating our AI-derived hypothesis for baricitinib as a possible #COVID19 treatment. benevolent.com/news/benevole…
A nice way to show awareness that marginalised communities in science need our support and we are far from equality @SammyKatta sammykatta.com/diversity
